Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Apr 24:20:587-591.
doi: 10.12659/AJCR.914304.

Post-Streptococcal Glomerulonephritis in Two Patients Following Deceased Donor Kidney Transplant

Affiliations
Case Reports

Post-Streptococcal Glomerulonephritis in Two Patients Following Deceased Donor Kidney Transplant

Miguel Tan et al. Am J Case Rep. .

Abstract

BACKGROUND Post-streptococcal glomerulonephritis (PSGN) is a well-known cause of renal injury. This disease is caused by a prior infection with specific nephritogenic strains of group A beta-hemolytic streptococcus resulting in formation of immune complexes in the glomeruli. Clinical presentation can range from asymptomatic, microscopic hematuria to the nephritic syndrome which is defined by red to brown urine, nephrotic range proteinuria, edema, hypertension, and acute kidney injury. A few reports have described PSGN in kidney transplant recipients in the post-transplantation period. However, biopsy-proven, donor-derived, PSGN in kidney transplant recipients has not been described. CASE REPORT Kidneys were donated from a 25-year-old Caucasian female with no history of hypertension or diabetes who had anoxic brain death in the setting of sepsis due to group A Streptococcus pyogenes bacteremia. The recipients were a 55-year-old male and a 68-year-old female, both of whom had end stage renal disease (ESRD) secondary to hypertensive nephrosclerosis. The recipients had kidney biopsies, one at the time of implantation and the other on post-operative day (POD) 2. Both biopsies showed streptococcal-associated glomerulonephritis. The prompt recognition and treatment of this disease in the immediate post-operative period resulted in histological resolution of the disease as well as good graft outcomes. CONCLUSIONS Utilizing kidneys from donors with streptococcal bacteremia is possible while maintaining a high degree of suspicion for possible streptococcal-associated glomerulonephritis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1.
Figure 1.
Renal biopsy from Recipient 1. (A) Proliferative glomerulonephritis (hematoxylin and eosin staining, original magnification 400×). (B) Endocapillary hypercellularity with neutrophilic exudates (Jones’ methenamine silver, original magnification 400×). (C) Mesangial C3 (direct immunofluorescence, original magnification 400×). (D) Mesangial immune deposits with small paramesangial hump at the mesangial reflection (arrow) (electron microscopy, original magnification 6000×).

Similar articles

Cited by

References

    1. Yuan X, Chen C, Zhou J, et al. Organ donation and transplantation from donors with systemic infection: A single-center experience. Transplant Proc. 2016;48(7):2454–57. - PubMed
    1. Simkins J, Muggia V. Favorable outcome in a renal transplant recipient with donor-derived infection due to multidrug-resistant Pseudomonas aeruginosa. J Transpl Infect Dis. 2012;14(3):292–95. - PubMed
    1. Kovacs CS, Jr, Koval CE, van Duin D, et al. Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections. World J Transplant. 2014;4(2):43–56. - PMC - PubMed
    1. Rodriguez-Iturbe B, Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int. 2007;71:1094–104. - PubMed
    1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–59. - PMC - PubMed

Publication types